Healthcare Distribution Alliance – Patients Move Us.
Share Print
blog banner

HDA Blog

Traceability Blog Entries

HDA Traceability Seminar to Feature FDA Update, Discussions on DSCSA Milestones

Posted by Perry L. Fri

As the summer winds down, HDA is hard at work planning our 2018 Traceability Seminar, which will take place three weeks earlier, on October 17–19 at the Renaissance Washington, DC Downtown Hotel. As the industry passes the halfway mark for DSCSA implementation, our 2018 agenda leverages HDA and our members’ unique expertise to help fellow stakeholders answer critical questions while planning for the multiple milestones ahead.

Read more...

Verification Router Service Progress Update

Posted by Justine Freisleben

As mentioned in our February 16 blog post, HDA and industry participants continue to make progress working with solution providers as Verification Router Service (VRS) solutions are developed for the 2019 DSCSA saleable returns requirement. This work has taken three paths: establishing governance processes; creating testing scenarios; and launching the testing phase.

Read more...

Three Takeaways from the FDA Public Meetings on DSCSA

Posted by Anita T. Ducca

On February 28, FDA hosted its third and final public meeting in a series focused on "Enhanced Drug Distribution Security Under the Drug Supply Chain Security Act [DSCSA],” bringing together a broad group of stakeholders, including manufacturers, distributors, dispensers, hospitals and service providers.

Read more...

Transitioning to Traceability — and a Verification Router Service Update

Posted by Perry L. Fri

As an organization, HDA has been looking for new ways to communicate the work happening around DSCSA implementation with a broader audience beyond twice a year at our Traceability Seminar and Distribution Management Conference. Beginning this month, the HDA blog is expanding to feature traceability/Drug Supply Chain Security Act (DSCSA) updates as well as HDA perspectives on a variety of related issues throughout the year.

Read more...

HDA’s John M. Gray Highlights State of the Distribution Industry in Chain Drug Review

Posted

Ahead of the HDA Business and Leadership Conference, President and CEO John M. Gray was interviewed by Chain Drug Review as part of the publication’s "Annual Report of Drug Wholesalers."

Read more...
View more
Website design and development by Americaneagle.com, inc
© 2018 Healthcare Distribution Alliance. All rights reserved.
HDA: M | C | D | NF | P | O365